MIR

New Software Release: Mirion Technologies has launched Apex-Guard™ Software Version 1.2, enhancing impurity analysis for radioisotope producers to meet regulatory demands and improve quality in cancer care.

Industry Impact: The software supports compliance with FDA regulations and streamlines workflows in the rapidly growing radiopharmaceutical sector, which is crucial for patient-centric diagnosis and treatment advancements.

Mirion's Role in Advanced Nuclear Project: Mirion has been chosen to supply the Radiation Monitoring System (RMS) and Nuclear Instrumentation System (XIS) for the Natrium Reactor Demonstration Project in Wyoming, marking a significant step in the U.S. commercial advanced nuclear power sector.

Commitment to Safety and Innovation: The contracts will enhance safety and operational efficiency at the plant, supporting innovative nuclear technologies while addressing modern energy demands through sustainable nuclear power solutions.

Mirion's New Memberships: Mirion has joined the Nuclear Energy Institute (NEI) and the American Nuclear Society (ANS) as a Trustee of Nuclear partner, enhancing its engagement with industry leaders and policymakers in the nuclear sector.

Commitment to Nuclear Advancement: CEO Thomas Logan emphasized Mirion's role in the Nuclear Renaissance and its commitment to advancing the nuclear industry through collaboration and innovative solutions.

Current Stock Performance: Mirion Technologies Inc (MIR) shares have entered oversold territory with an RSI of 28.5, indicating potential exhaustion of recent selling pressure, as the stock trades around $13.35, between its 52-week low of $9.11 and high of $18.81.

Market Comparison: The current RSI for the S&P 500 ETF (SPY) is 30.4, suggesting that MIR's lower RSI could present a buying opportunity for bullish investors looking for entry points.

Stock Performance Overview: MIR's stock has a 52-week low of $9.11 and a high of $18.81, with the last trade recorded at $13.30.

Disclaimer on Opinions: The views expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.

Upcoming Presentation: Mirion's CEO Thomas Logan and CFO Brian Schopfer will present at the 46th Annual Raymond James Institutional Investor Conference on March 5, 2025, at 9:15 a.m. ET, with a live webcast available on their Investor Relations Page.

Company Overview: Mirion is a global leader in radiation safety and medical solutions, employing around 2,800 people across 12 countries, focusing on innovations that enhance safety in various sectors including healthcare and nuclear facilities.

Company Presentation Announcement: Mirion's CEO Thomas Logan and CFO Brian Schopfer will present at Citi’s 2025 Global Industrial Tech and Mobility Conference on February 19, 2025, at 2:40 PM ET, with a live webcast available on their Investor Relations page.

About Mirion: Mirion is a global leader in radiation safety and medical technology, employing around 2,800 people across 12 countries, focusing on innovations that enhance safety in various sectors including healthcare and nuclear facilities.

Record Financial Performance: Mirion Technologies reported record revenue, adjusted EBITDA, and adjusted EPS for the fiscal year 2024, with strong growth in its Nuclear & Safety and Medical Groups, and a positive outlook for 2025 with significant backlog and order potential.

2025 Guidance: The company reaffirmed its financial guidance for 2025, projecting revenue growth of approximately 4.0% – 6.0%, adjusted EBITDA between $215 million - $230 million, and adjusted EPS of approximately $0.45 – $0.50 per share, despite facing foreign exchange rate headwinds.

Major Earnings Reports: Key companies reporting earnings after the market close on Tuesday include Energy Transfer LP, Gilead Sciences, W. P. Carey, Super Micro Computer, and Upstart Holdings.

Additional Earnings Releases: A wide range of other companies are also set to release their earnings, including ADC, AIG, LYFT, and SAGE among others.

Financial Results Announcement: Mirion will release its financial results for Q4 and full year 2024 on February 11, 2025, followed by a conference call on February 12, 2025, at 11:00 am ET.

Company Overview: Mirion is a global leader in radiation safety and medicine, employing around 2,800 people across 12 countries, providing essential technologies for various sectors including healthcare and nuclear facilities.

Fastest News Alerts: Benzinga Pro offers real-time intelligence and alerts to help traders stay informed and make winning trades in the stock market.

Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and accurate market intelligence.

Market Performance: U.S. stocks closed mixed, with the S&P 500 and Nasdaq reaching record highs after positive November jobs data, while the Dow experienced a decline for the week.

Analyst Ratings Insights: Benzinga's Analyst Ratings API provides curated stock ratings from top analysts, highlighting recent picks and price target adjustments for companies like Axon Enterprise and Chewy Inc., showcasing varying analyst accuracy and market predictions.

Fastest News Alerts: Benzinga Pro offers real-time intelligence and alerts to help traders stay informed and make winning trades in the stock market.

Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and accurate market intelligence.

Fiscal 2025 Financial Targets: Mirion Technologies will reveal its fiscal 2025 financial targets, expecting revenue growth of 4%-6% and EBITDA between $215 million and $230 million, with a long-term goal of reaching $1.1 billion in revenue by 2028.

Share Buyback Announcement: The company plans to initiate a share buyback program of up to $100 million during its Investor Day event.

Investor Day Announcement: Mirion will host an Investor Day on December 3, 2024, at the New York Stock Exchange, where they will discuss their strategic and financial outlook, including growth opportunities in nuclear power and cancer care, along with initial guidance for 2025 and a long-term financial outlook for 2028.

Share Repurchase Program: The company announced a $100 million share repurchase program to mitigate dilution from its incentive plan and enhance shareholder value, alongside a strategic partnership with Electronics Corporation of India Ltd to support India's nuclear sector growth.

Investor Day Announcement: Mirion will host an Investor Day on December 3, 2024, to discuss its strategic and financial outlook in the growing nuclear power and cancer care markets, including a $100 million share repurchase program and long-term revenue projections of approximately $1.1 billion by 2028.

Strategic Partnership Development: The company signed a Memorandum of Understanding with Electronics Corporation of India Ltd to support India's nuclear sector growth, leveraging both companies' expertise in radiation monitoring systems for local manufacturing and supply.

Financial Targets Announcement: Mirion Technologies will reveal its fiscal 2025 financial targets and long-term goals during its Investor Day, including a share buyback plan of up to $100 million.

Revenue Growth Expectations: The company anticipates a revenue growth of 4%-6% for fiscal 2025, with an organic increase of 5.5%-7.5%, aiming for approximately $1.1 billion in revenue by 2028.

Presentation Announcement: Mirion's CEO Thomas Logan and CFO Brian Schopfer will present at Goldman Sachs’ Industrials and Materials Conference on December 5, 2024, at 10:40 AM ET, with a live webcast available on their Investor Relations page.

Company Overview: Mirion is a global leader in radiation safety and medical technologies, employing around 2,800 people across 12 countries, focusing on innovations that enhance safety in various sectors including healthcare and nuclear facilities.

Goldman Sachs Price Target Update: Goldman Sachs has increased its price target for Mirion (MIR) from $13 to $16 while maintaining a Buy rating, despite the company's Q3 adjusted EBITDA falling short of expectations due to mixed performance across its segments.

Future Outlook and Investor Day: The firm believes that Mirion's guidance is achievable, supported by positive momentum in Nuclear new builds, and highlights the upcoming investor day on December 3rd as a potential catalyst for the stock.

Conference Call Announcement: Mirant Corp. will hold a conference call on October 30, 2024, at 11:00 AM ET to discuss its Q3 24 earnings results.

Access Information: The live webcast can be accessed online, and listeners can join the call via specific phone numbers or listen to a replay using provided access codes.